alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
---

---

Exhibit 14.1

# CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by
reference in the Registration Statements Form S-8 (File Nos. 333-102288 and 333-92491)
pertaining to the Employee Stock Option plans of NUR Macroprinters Ltd. (the
Company) and Form F-3 (File Nos. 333-115826, 333-114428, 333-47842 and 333-92493) of
the Company and in the related Prospectus of our report dated June 29, 2007, with respect
to the consolidated financial statements of NUR Macroprinters Ltd. and its subsidiaries
included in this Annual Report on Form 20-F for the year ended December 31, 2006.

| | /s/ Kost Forer Gabbay & Kasierer
KOST FORER GABBAY & KASIERER
A Member of Ernst & Young Global
| | ----------------------------------------------------------------------------------------------

Tel Aviv, Israel 
June 29, 2007



---

---
---

---

Exhibit 14.2

# CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by
reference in the Registration Statements of NUR Macroprinters Ltd. on Form S-8 (File Nos.
333-102288 and 333-92491) and Form F-3 (File Nos. 333-115826, 333-114428, 333-47842 and
333-92493) of our report dated June 2, 2005 relating to the financial statements of NUR
Asia Pacific Limited for the year ended December, 31, 2004 with respect to the
Consolidated Financial Statements of NUR Macroprinters Ltd., included in its Amendment no.
1 to the annual report on Form 20-F for the year ended December 31, 2004 filed with the
United States Securities and Exchange Commission.

/s/ BDO McCabe Lo & Company
BDO McCabe Lo & Company
Certified Public Accountants
March 9, 2006



---

---
### UNPUBLISHED



# UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT



#  U NITED S TATES OF A MERICA ,

Plaintiff-Appellee,
v. No. 01-4326



# 
P AUL A NTHONY H AUSE ,

Defendant-Appellant. 

# 
Appeal from the United States District Court for the Northern District of West Virginia, at Martinsburg.

W. Craig Broadwater, District Judge.

(CR-00-47) Submitted: September 25, 2001 Decided: December 13, 2001 Before WILKINS, MOTZ, and GREGORY, Circuit Judges.

Affirmed by unpublished per curiam opinion.

COUNSEL Mark Jenkinson, DOUGLAS & JENKINSON, Martinsburg, West Virginia, for Appellant. Patrick M. Flatley, United States Attorney, Paul T. Camilletti, Assistant United States Attorney, Wheeling, West Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).OPINION
PER CURIAM: Paul Hause appeals from the twenty-one month sentence imposed upon his guilty plea to being a felon in possession of a firearm, 18 U.S.C. § 922(g) (1994). Hause argues that the district court should have reduced his offense level pursuant to U.S. Sentencing Guidelines Manual § 2K2.1(b)(2) (2000), because he possessed the firearm for collection purposes only. Hause testified that he received the gun in 1996 as partial payment on an automobile which he sold. Hause pawned the gun twice, in late 1996 and in early 1997, and did not redeem it after the second time. A firearms expert testified that the gun was an inexpensive handgunand that it was not the sort of firearm that would be considered a collectible. Based on this evidence, we cannot say that the district court clearly erred in denying Hause an adjustment under § 2K2.1(b)(2). United States v. Daughtrey , 874 F.2d 213, 217-18 (4th Cir. 1989). Accordingly, we affirm his sentence. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process. AFFIRMED 2 U NITED S TATES v. H AUSE
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from the Balance
Sheet and Statement of Operations as of and for the 26 weeks ended August 1,
1998 and is qualified in its entirety by reference to such financial statements
as included in the Company's Quarterly Report on Form 10-Q.
</LEGEND>
<CIK>                                          0000813775
<NAME>                                         Family Bargain Corporation
<MULTIPLIER>                                   1,000
       
<S>                                            <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              JAN-30-1999
<PERIOD-START>                                 FEB-1-1998
<PERIOD-END>                                   AUG-1-1998
<CASH>                                         4,483
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    40,864
<CURRENT-ASSETS>                               48,313
<PP&E>                                         25,600
<DEPRECIATION>                                 10,022
<TOTAL-ASSETS>                                 98,620
<CURRENT-LIABILITIES>                          42,241
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    36
<COMMON>                                       50
<OTHER-SE>                                     9,577
<TOTAL-LIABILITY-AND-EQUITY>                   98,620
<SALES>                                        139,951
<TOTAL-REVENUES>                               139,951
<CGS>                                          93,142
<TOTAL-COSTS>                                  93,142
<OTHER-EXPENSES>                               48,205
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             2,372
<INCOME-PRETAX>                                (3,768)
<INCOME-TAX>                                   99
<INCOME-CONTINUING>                            (3,867)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                (2,750)
<CHANGES>                                      0
<NET-INCOME>                                   (6,617)
<EPS-PRIMARY>                                  (1.97)
<EPS-DILUTED>                                  (1.97)
        


</TABLE>
IN THE SUPREME COURT OF PENNSYLVANIA 

MIDDLE DISTRICT 

COMMONWEALTH OF PENNSYLVANIA, 

 Respondent 

 v. 

JONATHAN M. GIANNOTTO, 

 Petitioner 

:

:

:

:

:

:

:

:

:

:

:

No. 930 MAL 2015 

Petition for Allowance of Appeal from 

the Order of the Superior Court 

ORDER 

PER CURIAM 

AND NOW, this 6th day of April, 2016, the Petition for Allowance of Appeal is 

DENIED. 

Justice Wecht did not participate in the consideration or decision of this matter.
Editorial Note on Part 117
Editorial Note: Nomenclature changes to part 117 appear at 81 FR 49896, July 29, 2016.

§ 117.126 Food safety plan. ( a ) *Requirement for a food safety plan.* ( 1 ) You must prepare, or have prepared, and implement a written food safety plan.
( 2 ) The food safety plan must be prepared, or its preparation overseen, by one or more preventive controls qualified individuals.
( b ) *Contents of a food safety plan.* The written food safety plan must include: ( 1 ) The written hazard analysis as required by § 117.130(a)(2);
( 2 ) The written preventive controls as required by § 117.135(b);
( 3 ) The written supply-chain program as required by subpart G of this part;
( 4 ) The written recall plan as required by § 117.139(a); and
( 5 ) The written procedures for monitoring the implementation of the preventive controls as required by § 117.145(a);
( 6 ) The written corrective action procedures as required by § 117.150(a)(1); and
( 7 ) The written verification procedures as required by § 117.165(b).
( c ) *Records.* The food safety plan required by this section is a record that is subject to the requirements of subpart F of this part.
[80 FR 56145, Sept. 17, 2015, as amended at 84 FR 12491, Apr. 2, 2019]
§ 211.180 General requirements. ( a ) Any production, control, or distribution record that is required to be maintained in compliance with this part and is specifically associated with a batch of a drug product shall be retained for at least 1 year after the expiration date of the batch or, in the case of certain OTC drug products lacking expiration dating because they meet the criteria for exemption under § 211.137, 3 years after distribution of the batch.
( b ) Records shall be maintained for all components, drug product containers, closures, and labeling for at least 1 year after the expiration date or, in the case of certain OTC drug products lacking expiration dating because they meet the criteria for exemption under § 211.137, 3 years after distribution of the last lot of drug product incorporating the component or using the container, closure, or labeling.
( c ) All records required under this part, or copies of such records, shall be readily available for authorized inspection during the retention period at the establishment where the activities described in such records occurred. These records or copies thereof shall be subject to photocopying or other means of reproduction as part of such inspection. Records that can be immediately retrieved from another location by computer or other electronic means shall be considered as meeting the requirements of this paragraph.
( d ) Records required under this part may be retained either as original records or as true copies such as photocopies, microfilm, microfiche, or other accurate reproductions of the original records. Where reduction techniques, such as microfilming, are used, suitable reader and photocopying equipment shall be readily available.
( e ) Written records required by this part shall be maintained so that data therein can be used for evaluating, at least annually, the quality standards of each drug product to determine the need for changes in drug product specifications or manufacturing or control procedures. Written procedures shall be established and followed for such evaluations and shall include provisions for: ( 1 ) A review of a representative number of batches, whether approved or rejected, and, where applicable, records associated with the batch.
( 2 ) A review of complaints, recalls, returned or salvaged drug products, and investigations conducted under § 211.192 for each drug product.
( f ) Procedures shall be established to assure that the responsible officials of the firm, if they are not personally involved in or immediately aware of such actions, are notified in writing of any investigations conducted under §§ 211.198, 211.204, or 211.208 of these regulations, any recalls, reports of inspectional observations issued by the Food and Drug Administration, or any regulatory actions relating to good manufacturing practices brought by the Food and Drug Administration.
[43 FR 45077, Sept. 29, 1978, as amended at 60 FR 4091, Jan. 20, 1995]
From: Sharon Nizich/RTP/USEPA/US@EPA

Sent: 05/02/2012 03:21 PM

To: "Higgins, Cortney" <Cortney_Higgins@omb.eop.gov>, Keith 

Barnett/RTP/USEPA/US@EPA, Peter Westlin/RTP/USEPA/US@EPA, Steven 

Silverman/DC/USEPA/US@EPA, Steffan Johnson/RTP/USEPA/US@EPA, Charlotte 

Bertrand/DC/USEPA/US@EPA, Tom Walton/RTP/USEPA/US@EPA, Amy 

Lamson/RTP/USEPA/US@EPA

Cc:

Subject: Discussion on May 7 regarding Portland Cement

Please note an outline is attached for our preliminary discussion on the Portland Cement 

Reconsideration Package.

(See attached file: Portland Cement summary of proposal May 2012.docx)

Sharon V. Nizich

Minerals and Manufacturing Group (MMG)

Sector Policies and Programs Division

OAQPS - US EPA

RTP NC 27711

919/541-2825
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7284 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7284

To prohibit the Environmental Protection Agency from using assessments 
 generated by the Integrated Risk Information System as a tier 1 data 
   source in rulemakings and other regulatory actions, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 7, 2024

 Mr. Grothman introduced the following bill; which was referred to the 
Committee on Energy and Commerce, and in addition to the Committees on 
Agriculture, and Transportation and Infrastructure, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL

 
To prohibit the Environmental Protection Agency from using assessments 
 generated by the Integrated Risk Information System as a tier 1 data 
   source in rulemakings and other regulatory actions, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``No Industrial Restrictions in Secret 
Act of 2024'' or the ``No IRIS Act of 2024''.

SEC. 2. PROHIBITION ON USE OF ASSESSMENTS GENERATED BY THE INTEGRATED 
              RISK INFORMATION SYSTEM PROGRAM.

    Notwithstanding any other provision of law, the Administrator of 
the Environmental Protection Agency may not use any assessment 
generated by the Integrated Risk Information System program of the 
Environmental Protection Agency as the primary data source--
            (1) to develop, finalize, or issue a rule or regulation;
            (2) to carry out any other regulatory action; or
            (3) to inform the National Air Toxics Assessment.
                                 <all>
```
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.190 THBP. The food additive THBP (2,4,5-trihydroxybutyrophenone) may be safely used in food in accordance with the following prescribed conditions: ( a ) The food additive has a melting point of 149 °C-153 °C.
( b ) It is used as an antioxidant alone or in combination with other permitted antioxidants.
( c ) The total antioxidant content of a food containing the additive will not exceed 0.02 percent of the oil or fat content of the food, including the essential (volatile) oil content of the food.
EXHIBIT 32.1





CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the accompanying Quarterly Report on Form 10-Q of Southwall Technologies Inc. (the "Company"), for the quarter ended September 28, 2003, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas G. Hood, the Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results ofoperations of the Company.







| | November 17, 2003 | By: |                                       
| | ----------------- | --- | --------------------------------------
| |                   |     | Thomas G. Hood
Chief Executive Officer



A signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

In accordance with Item 601 of Regulation S-K, this certification is being "furnished" as Exhibit 32.1 to the Company's quarterly report and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
§ 139.115 Enriched macaroni products. ( a ) *Description.* Enriched macaroni products are the class of food each of which conforms to the definition and standard of identity and is subject to the requirements for label statement of ingredients, prescribed for macaroni products by § 139.110(a), (f), and (g), except that: ( 1 ) Each such food contains in each pound not less than 4.0 milligrams (mg) and not more than 5.0 mg of thiamin, not less than 1.7 mg and not more than 2.2 mg of riboflavin, not less than 27 mg and not more than 34 mg of niacin or niacinamide, not less than 0.9 mg and not more than 1.2 mg of folic acid, and not less than 13 mg and not more than 16.5 mg of iron (Fe);
( 2 ) Each such food may also contain as an optional ingredient added vitamin D in such quantity that each pound of the finished food contains not less than 250 U.S.P. units and not more than 1000 U.S.P. units of vitamin D.
( 3 ) Each such food may also contain as an optional ingredient added calcium in such quantity that each pound of the finished food contains not less than 500 mg. and not more than 625 mg. of calcium (Ca);
( 4 ) Each such food may also contain as an optional ingredient partly defatted wheat germ but the amount thereof does not exceed 5 percent of the weight of the finished food;
( 5 ) Each such food may be supplied, wholly or in part, with the prescribed quantity of any substance referred to in paragraphs (a) (1), (2), and (3) of this section through the use of dried yeast, dried torula yeast, partly defatted wheat germ, enriched farina, or enriched flour, or through the direct additions of any of the substances prescribed in paragraphs (a) (1), (2), and (3) of this section. Iron and calcium may be added only in forms which are harmless and assimilable. The substances referred to in paragraphs (a) (1) and (2) of this section may be added in a harmless carrier which does not impair the enriched macaroni product, such carrier being used only in the quantity reasonably necessary to effect an intimate and uniform distribution of such substances in the finished enriched macaroni product.
( b ) Enriched macaroni is the enriched macaroni product the units of which conform to the specifications of shape and size prescribed for macaroni by § 139.110(b).
( c ) Enriched spaghetti is the enriched macaroni product the units of which conform to the specifications of shape and size prescribed for spaghetti by § 139.110(c).
( d ) Enriched vermicelli is the enriched macaroni product the units of which conform to the specifications of shape and size prescribed for vermicelli by § 139.110(d).
( e ) The name of each food for which a definition and standard of identity is prescribed by this section is “Enriched Macaroni product”; or alternatively, the name is “Enriched macaroni”, “Enriched spaghetti”, or “Enriched vermicelli”, as the case may be, when the units of the food comply with the requirements of paragraphs (b), (c), or (d) respectively of this section.
[42 FR 14409, Mar. 15, 1977, as amended at 58 FR 2878, Jan. 6, 1993; 61 FR 8797, Mar. 5, 1996]
§ 26.3 Scope. ( a ) The provisions of this subpart shall apply to pharmaceutical inspections carried out in the United States and Member States of the European Community (EC) before products are marketed (hereafter referred to as “preapproval inspections”) as well as during their marketing (hereafter referred to as “postapproval inspections”).
( b ) Appendix A of this subpart names the laws, regulations, and administrative provisions governing these inspections and the good manufacturing practices (GMP's) requirements.
( c ) Appendix B of this subpart lists the authorities participating in activities under this subpart.
( d ) Sections 26.65, 26.66, 26.67, 26.68, 26.69, and 26.70 of subpart C of this part do not apply to this subpart.
§ 182.7255 Chondrus extract. ( a ) *Product.* Chondrus extract (carrageenin).
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing practice.
###### Editorial Note on Part 170

#### Editorial Note:

Nomenclature changes to part 170 appear at 66 FR 56035, Nov. 6, 2001, and 69 FR 13717, Mar. 24, 2004.

#### § 170.19 Pesticide chemicals in processed foods.

When pesticide chemical residues occur in processed foods due to the use of raw agricultural commodities that bore or contained a pesticide chemical in conformity with an exemption granted or a tolerance prescribed under section 408 of the Act, the processed food will not be regarded as adulterated so long as good manufacturing practice has been followed in removing any residue from the raw agricultural commodity in the processing (such as by peeling or washing) and so long as the concentration of the residue in the processed food when ready to eat is not greater than the tolerance prescribed for the raw agricultural commodity. But when the concentration of residue in the processed food when ready to eat is higher than the tolerance prescribed for the raw agricultural commodity, the processed food is adulterated unless the higher concentration is permitted by a tolerance obtained under section 409 of the Act. For example, if fruit bearing a residue of 7 parts per million of DDT permitted on the raw agricultural commodity is dried and a residue in excess of 7 parts per million of DDT results on the dried fruit, the dehydrated fruit is adulterated unless the higher tolerance for DDT is authorized by the regulations in this part. Food that is itself ready to eat, and which contains a higher residue than allowed for the raw agricultural commodity, may not be legalized by blending or mixing with other foods to reduce the residue in the mixed food below the tolerance prescribed for the raw agricultural commodity.
----

----

| A) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----|-----------------------------------------------------------------------------------------------------------------------|

| B) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |   | /s/ Ran Fridrich   |   |
|--------|--------|-------------------------|--------|
|   |   | Ran Fridrich       |   |
|   |   | Chief Executive Officer |   |
|   |   |                    |   |

|   |   | /s/ Kalia Weintraub |   |
|--------|--------|--------------------------|--------|
|   |   | Kalia Weintraub          |   |
|   |   | Chief Financial Officer  |   |
|   |   |                     |   |

----

----